Filing Details

Accession Number:
0001385508-22-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-13 16:55:35
Reporting Period:
2022-06-10
Accepted Time:
2022-06-13 16:55:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363558 A Craig Collard C/O Opiant Pharmaceuticals, Inc.
233 Wilshire Blvd., Suite 400
Santa Monica CA 90401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-10 1,663 $11.50 49,785 No 4 P Direct
Common Stock Acquisiton 2022-06-13 4,037 $10.94 53,822 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $11.48 to $11.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $10.82 to $10.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.